在澳大利亚土著人口中,类风湿性关节炎的流行病学和并发症
Johannes C Nossent1, Helen I Keen2,3, David B Preen4
1Rheumatology Group, School of Medicine, University Western Australia, 35 Stirling Highway (M503), Perth, WA, Australia. johannes.nossent@uwa.edu.au.
Rheumatology international
|August 7, 2025
概括
类风湿性关节炎 (RA) 影响澳大利亚土著 (IA) 与非土著 (NI) 澳大利亚人的频率相似. 然而,IA患者的诊断年龄较小,尽管密集护理较少,但死亡率较高.
科学领域:
- 类风湿病学 类风湿病学
- 流行病学 流行病学
- 土著健康土著健康
背景情况:
- 类风湿性关节炎 (RA) 的表现和结果在不同人群中可能有很大差异.
- 有关RA发病率,流行率和澳大利亚土著 (IA) 的临床结果的数据严重缺乏.
研究的目的:
- 确定和比较RA在澳大利亚土著 (IA) 与非土著 (NI) 澳大利亚人的发病率和流行率.
- 分析和比较RAIAIA和NI患者之间的临床结果,医疗保健利用率和死亡率.
主要方法:
- 一项基于人口的队列研究,利用跨越30年的纵向行政健康数据.
- 每10万人口的疾病发病率 (IR) 和点流行率 (PR) 的比较.
- 对临床结果的分析,包括再入院,急诊室访问,手术手术,并发病和死亡率.
主要成果:
- 在IA和NI群体中,RA发病率和流行率在IA和NI群体中相似.
- 患有RA的IA患者在诊断时更年轻,吸烟,糖尿病和肥胖率更高.
- IA患者的关节手术和骨质疏松率较低,但骨折率较高;AI患者的死亡率明显较高,心血管事件是死亡的主要原因.
结论:
- 类风湿性关节炎 (RA) 在澳大利亚土著 (IA) 和非土著 (NI) 人群中发生的频率相似.
- 患有RA的IA患者在较年轻时出现,具有相似的关节外表现,但接受的类风湿病治疗较少,死亡率更高.
- 这些发现突出了RA护理和澳大利亚土著人的结果的显著差异,需要有针对性的干预措施.
相关概念视频
01:23Rheumatic Heart Disease I: Introduction
40
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
40
01:11Genome-wide Association Studies-GWAS
14.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.2K
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
58
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
58
01:21Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
01:20Rheumatic Heart Disease IV: Nursing Management
38
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
38
01:20The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K